Skip to content

Author

Xu Liu

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

The efficacy and feasibility of neoadjuvant immunochemotherapy versus chemotherapy in Limited-Stage Small-Cell lung cancer.

BACKGROUND The efficacy of neoadjuvant immunochemotherapy (NIC) in limited-stage small-cell lung cancer (LS-SCLC) remains undefined. This study aimed to evaluate the pathological and survival outcomes of NIC versus neoadjuvant chemotherapy (NC) and to compare NIC with upfront surgery in a real-world setting. MATERIAL...

Yun-Chu Wei, Ruo-Yi Jin, Xu Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.